相似文献
1
AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.
Neuron. 2006 Dec 7;52(5):831-43. doi: 10.1016/j.neuron.2006.10.035.
2
AKAP150-anchored calcineurin regulates synaptic plasticity by limiting synaptic incorporation of Ca2+-permeable AMPA receptors.
J Neurosci. 2012 Oct 24;32(43):15036-52. doi: 10.1523/JNEUROSCI.3326-12.2012.
3
Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.
Eur J Neurosci. 2014 Apr;39(7):1214-24. doi: 10.1111/ejn.12507.
4
GluR1 links structural and functional plasticity at excitatory synapses.
J Neurosci. 2007 Dec 12;27(50):13706-18. doi: 10.1523/JNEUROSCI.3503-07.2007.
5
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x.
6
Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.
Mol Brain. 2010 Mar 26;3:10. doi: 10.1186/1756-6606-3-10.
7
The N-methyl-D-aspartate receptor antagonist CPP alters synapse and spine structure and impairs long-term potentiation and long-term depression induced morphological plasticity in dentate gyrus of the awake rat.
Neuroscience. 2010 Feb 17;165(4):1170-81. doi: 10.1016/j.neuroscience.2009.11.047. Epub 2009 Dec 1.
8
Enhancement of long-term depression by soluble amyloid β protein in rat hippocampus is mediated by metabotropic glutamate receptor and involves activation of p38MAPK, STEP and caspase-3.
Neuroscience. 2013 Dec 3;253:435-43. doi: 10.1016/j.neuroscience.2013.08.054. Epub 2013 Sep 5.
9
Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.
J Biol Chem. 2010 Mar 5;285(10):7619-32. doi: 10.1074/jbc.M109.057182. Epub 2009 Dec 23.
10
ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity.
Nat Neurosci. 2010 Oct;13(10):1208-15. doi: 10.1038/nn.2634. Epub 2010 Sep 12.
引用本文的文献
1
Impact of Dendritic Spine Loss on Excitability of Hippocampal CA1 Pyramidal Neurons: A Computational Study of Early Alzheimer Disease.
Hippocampus. 2025 Sep;35(5):e70025. doi: 10.1002/hipo.70025.
2
Caspase cleavage of APP contributes to amyloid beta-protein induced synaptic injury.
bioRxiv. 2025 May 7:2025.04.30.651606. doi: 10.1101/2025.04.30.651606.
3
Blunted pressor response to peripheral sensory afferent nerve stimulation in intracerebroventricular-streptozotocin injected rats.
Auton Neurosci. 2025 Aug;260:103315. doi: 10.1016/j.autneu.2025.103315. Epub 2025 Jun 18.
4
Dual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease.
J Alzheimers Dis Rep. 2025 Jun 2;9:25424823251341870. doi: 10.1177/25424823251341870. eCollection 2025 Jan-Dec.
5
The interaction between neurotransmitter receptor activity and amyloid-β pathology in Alzheimer's disease.
J Alzheimers Dis. 2025 Jul;106(2):391-409. doi: 10.1177/13872877251342273. Epub 2025 Jul 1.
6
Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches.
J Neurosci Res. 2025 May;103(5):e70046. doi: 10.1002/jnr.70046.
7
GluN2B suppression restores phenylalanine-induced neuroplasticity and cognition impairments in a mouse model of phenylketonuria.
J Clin Invest. 2025 May 8;135(13). doi: 10.1172/JCI184299. eCollection 2025 Jul 1.
8
Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease.
Alzheimers Dement. 2025 Mar;21(3):e70030. doi: 10.1002/alz.70030.
9
Future Perspectives of NMDAR in CNS Disorders.
Molecules. 2025 Feb 14;30(4):877. doi: 10.3390/molecules30040877.
10
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.
Transl Neurodegener. 2025 Feb 11;14(1):8. doi: 10.1186/s40035-025-00470-z.
本文引用的文献
1
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3410-5. doi: 10.1073/pnas.0507313103. Epub 2006 Feb 21.
2
Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation.
J Neurosci. 2006 Feb 15;26(7):2000-9. doi: 10.1523/JNEUROSCI.3918-05.2006.
3
Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.
Neuron. 2005 Dec 22;48(6):913-22. doi: 10.1016/j.neuron.2005.10.028.
4
Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.
J Neurosci. 2005 Nov 30;25(48):11061-70. doi: 10.1523/JNEUROSCI.3034-05.2005.
5
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.
Neurobiol Dis. 2005 Nov;20(2):187-98. doi: 10.1016/j.nbd.2005.02.008.
6
Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy.
J Neurosci. 2005 Aug 3;25(31):7278-87. doi: 10.1523/JNEUROSCI.1879-05.2005.
7
Regulation of NMDA receptor trafficking by amyloid-beta.
Nat Neurosci. 2005 Aug;8(8):1051-8. doi: 10.1038/nn1503. Epub 2005 Jul 17.
8
Development of long-term dendritic spine stability in diverse regions of cerebral cortex.
Neuron. 2005 Apr 21;46(2):181-9. doi: 10.1016/j.neuron.2005.04.001.
9
Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.
Genes Brain Behav. 2005 Apr;4(3):173-96. doi: 10.1111/j.1601-183X.2005.00124.x.
10
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.
Neuron. 2005 Mar 3;45(5):675-88. doi: 10.1016/j.neuron.2005.01.040.
Zotero 插件